Patent · US Expired

Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease

US7638480B2 · kind B2 · utility

9Cited by
9References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2003
Grant dateDec 29, 2009
Priority date
Expiry dateMar 10, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of osteoprotegerin for treatment and/or prevention of fibrotic diseases, in particular of scleroderma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.